100 Years of Yellow Jackets Athletics
August 20, 2024 10:10 ET
|
Cedarville University
CEDARVILLE, OHIO, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Athletic excellence has been a hallmark of Cedarville University for more than a century, almost since its founding in 1887. Now, in 2024,...
K9 Power Products Wins “Dog Skin & Coat Product of the Year” In 2024 Pet Innovation Awards
August 15, 2024 08:06 ET
|
Pet Innovation Awards
LOS ANGELES, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The 2024 Pet Innovation Awards, an independent recognition platform highlighting the most innovative companies, services, and products in the highly...
Super League Announces Second Quarter 2024 Financial Results
August 14, 2024 16:51 ET
|
Super League Enterprise
~ Q2 2024 Highlighted by Launch of Innovative Scalable Products, SOUNDZ and Unlockables, New Dedicated Worlds and a Strategic Partnership with Meta-Stadiums~ ~ Net Loss Improvement in Q2 2024...
Decisely Celebrates its Place on the 2024 Inc. 5000 List of Fastest-Growing Private Companies
August 14, 2024 14:30 ET
|
Decisely
ALPHARETTA, GA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Decisely, a leading provider of health benefits and management solutions for business owners, is proud to announce its inclusion in the prestigious...
Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potential of the Oligonucleotide Transport Vehicle Platform to Achieve Broad Biodistribution of Antisense Oligonucleotides in the CNS and Muscle Following Intravenous Administration
August 14, 2024 14:00 ET
|
Denali Therapeutics Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to...
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
August 13, 2024 07:15 ET
|
Mural Oncology, Inc.
Company remains well positioned to capitalize on the role of cytokines with near- and long-term potential value creation milestones, reiterates guidance on projected cash runway into Q4 2025 On...
Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
August 13, 2024 07:00 ET
|
Chimerix, Inc.
– Phase 3 ACTION Study On-Track; First Interim Overall Survival Data Expected Third Quarter 2025 – – ONC206 Phase 1 PK and Safety Data Demonstrate Dose Proportional Exposure with No Dose...
ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates
August 12, 2024 16:05 ET
|
ORIC Pharmaceuticals
Initiated dosing of ORIC-944 in combinations with NUBEQA® (darolutamide) and ERLEADA® (apalutamide) in the ongoing Phase 1b trial for prostate cancer Entered into clinical trial collaboration and...
Indaptus Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 12, 2024 08:00 ET
|
Indaptus Therapeutics
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer...
Games & Puzzles Market by Games Type (Board Games, Card Games, Puzzles), Licensing (Licensed, Non-Licensed), Age Group, Distribution, Game Theme - Global Forecast 2024-2030
August 09, 2024 04:13 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Games & Puzzles Market by Games Type (Board Games, Card Games, Puzzles), Licensing (Licensed, Non-Licensed), Age Group, Distribution, Game...